Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial

NCT05932472 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

32706

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Cardiovascular Diseases
Drug Effect

Interventions

DRUG: Aspirin

Sponsor

Tor Biering-Sørensen